Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

369 evidence items · page 15 / 15

93.3 %The majority (93.3%) of patients was symptomatic.

Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

4.7 log10_copies_per_mlAt baseline, the median plasma HIV-1 RNA was 4.7 log10 copies/ml [IQR 4.0–5.2] in HIV-infected adults in the Temprano trial.

Côte d'IvoireVIH/sidapublished 2020EBioMedicineeurope_pmcdocument of 7 observations

67.7 %21 (67.7%) HIV-2 patients switched at least one antiretroviral drug.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

341 /mm³Median CD4+ T-cell count was 341/mm³ among 491 adult HIV patients.

Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations

48 %Among hospitalized HIV-positive adults in West Africa, 48% had previously received antiretroviral treatment.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

73.3 %73.3% of 491 adult HIV patients were female.

Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations

69 %HIV-2 resistance mutations to protease inhibitors were detected in 20 of 29 (69%) samples.

Côte d'IvoireVIH/sidapublished 2014AIDS (London, England)europe_pmcdocument of 9 observations

1,754 patientsThe study included 1,754 HIV-2 and HIV-1/HIV-2 dually seropositive patients.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

45.3 yearsAt ART initiation, the median age of HIV-2 patients was 45.3 years.

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

66 %Among the 220 patients receiving ART, 145 (66.0%) had CD4-T cell count ≤ 500 cells/mm3.

Côte d'IvoireVIH/sidaobserved 2012published 2015PloS oneeurope_pmcdocument of 9 observations

128 consultationsFrom January 1st, 2000 to December 31st, 2007, 128 consultations for non-occupational HIV exposure were managed in the Abidjan infectious diseases department.

Côte d'IvoireVIH/sidaobserved 2000-2007published 2010Medecine et maladies infectieuseseurope_pmcdocument of 13 observations

8.3 per_100_person-yearsThe incidence of first serious event among HIV-infected adults receiving antiretroviral treatment was 8.3 per 100 person-years thereafter.

Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

551 patientsAmong HIV-2 infected patients, 551 were on antiretroviral therapy (ART).

Côte d'IvoireVIH/sidapublished 2013PloS oneeurope_pmcdocument of 14 observations

118 cells/μLThe mean CD4 cell count increase at month-12 among HIV-2 infected patients on antiretroviral therapy was +118 cells/μL.

Côte d'IvoireVIH/sidaobserved month-12published 2014BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/1471-2334-14-461

4 %Among 66 patients with non-clinical HIV risk indicators, only 11 (4.0%) mentioned it to a health professional.

Côte d'IvoireVIH/sidaobserved 2013–2014published 2017PloS oneeurope_pmcdocument of 5 observations

2.7 odds_ratioLiver cancer was associated with HIV infection with an odds ratio of 2.7.

Côte d'Ivoirecarcinome hépatocellulaire · VIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108

5 per_100_person_yearsIn patients with pre-ANT CD4 cell count <200 cells/μL, incidence of mortality was 5.0 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations

Adult patients infected with HIV-1 or HIV-1/HIV-2 initiated antiretroviral treatment between January 2003 and December 2008.

Côte d'IvoireHIV-1/HIV-2 · VIH/sidaobserved January 2003 to December 2008published 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

79.6 %At the initiation of antiretroviral therapy, 79.6% of patients had a CD4 count less than 200/mm³.

Côte d'IvoireVIH/sidapublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.